MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway
Biochemical Pharmacology · 2024
DOI: 10.1016/j.bcp.2024.116372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Wenhao Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research…. Hauptthemen laut MEDLINE: MicroRNAs, GTP Phosphohydrolases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Harbin Medical University.
Abstract (Originalsprache)
MicroRNA and mitofusin-2 (Mfn2) play an important role in the myocardial apoptosis induced by acute myocardial infarction (AMI). However, the target relationship and underlying mechanism associated with interorganelle interaction between endoplasmic reticulum (ER) and mitochondria under ischemic condition is not completely clear. MI-induced injury, Mfn2 expression, Mfn2-mediated mitochondrial function and ER stress, and target regulation by miRNA-15b (miR-15b) were evaluated by animal MI and cellular hypoxic models with advanced molecular techniques. The results confirmed that Mfn2 was down-regulated and miR-15b was up-regulated upon the target binding profile under ischemic/hypoxic condition. Our data showed that miR-15b caused cardiac apoptotic injury that was reversed by rAAV9-anti-miR-15b or AMO-15b. The damage effect of miR-15b on Mfn2 expression and mitochondrial function was observed and rescued by rAAV9-anti-miR-15b or AMO-15b. The targeted regulation of miR-15b on Mfn2 was verified by luciferase reporter and microRNA-masking. Importantly, miR-15b-mediated Mfn2 suppression activated PERK/CHOP pathway, by which leads to ER stress and mitochondrial dysfunction, and cardiac apoptosis eventually. In conclusion, our research, for the first time, revealed the missing molecular link in Mfn2 and apoptosis and elucidated that pro-apoptotic miR-15b plays crucial roles during the pathogenesis of AMI through down-regulation of Mfn2 and activation of PERK-mediated ER stress. These findings may provide an opportunity to develop new therapies for prophylaxis and treatment of ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical Universi…
Förderung
- National Natural Science Foundation of China
- Harbin Medical University
Zitieren
APA
Zhang, W., Zhang, M., Ma, J., Yao, Y., Jiang, Y., Huo, Q., Jin, S., Ji, D., Zhao, Y., Liu, X., Sun, H., Xu, C., & Zhang, R. (2024). MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116372
Vancouver
Zhang W, Zhang M, Ma J, Yao Y, Jiang Y, Huo Q, et al. MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116372
BibTeX
@article{Zhang2024,
author = {Zhang, Wenhao and Zhang, Mingyu and Ma, Jiao and Yao, Yuan and Jiang, Yuan and Huo, Qingji and Jin, Saidi and Ji, Dongni and Zhao, Yilin and Liu, Xinqi and Sun, Hao and Xu, Chaoqian and Zhang, Rong},
title = {MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway},
journal = {Biochemical Pharmacology},
year = {2024},
doi = {10.1016/j.bcp.2024.116372}
}
EUVIMED